Pregnancy and the susceptibility of Lewis rats to experimental allergic encephalomyelitis

Pregnant Lewis rats challenged with encephalitogen during the second or third week of gestation were afforded a high level of protection against experimental allergic encephalomyelitis, whilst females sensitised during the first week of pregnancy enjoyed only limited protection from clinical signs of disease. When rechallenged with encephalitogen, females which had been sensitised during pregnancy were marginally more susceptible to reinduction of clinical signs of disease than their virgin counterparts. Mothers inoculated during the first week of gestation were the only group to produce abnormal young.